Form 4 for MSTR Strategy Inc
Accepted 2025-03-26 00:00:00 ET · period of report 2025-03-25 · accession 0000950170-25-045558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-26 | 2025-03-25 | MSTR | RECHAN LESLIE J | Dir | S - Sale+OE | $335.90 | -15.0K | 4,970 | -75% | -$5.04M |
| DM | 2025-03-26 | 2025-03-25 | MSTR | RECHAN LESLIE J | Dir | M - OptEx | $13.07 | +15.0K | 15.0K | New | +$196.1K |
| DM | 2025-03-26 | 2025-03-25 | MSTR | RECHAN LESLIE J | Dir | M - OptEx | $0.00 | -15.0K | 20.0K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-25 | S | D | 7,200 | $335.31 | 12,770 | D | — | — | (F1) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.00 to $335.70, inclusive. The reporting person undertakes to provide to MicroStrategy Incorporated d/b/a Strategy ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
| 2 | Common | Class A Common Stock | 2025-03-25 | M | A | 5,000 | $13.29 | 19,970 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-03-25 | M | A | 10,000 | $12.96 | 14,970 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-03-25 | S | D | 7,600 | $336.42 | 5,170 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.00 to $336.91, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
| 5 | Common | Class A Common Stock | 2025-03-25 | S | D | 200 | $337.15 | 4,970 | D | — | — | |
| 6 | Derivative | Director Stock Option (Right to buy) | 2025-03-25 | M | D | 10,000 | $0.00 | 0 | D | $12.96 · — to 2028-05-31 | 10,000 Class A Common Stock | (F3) The 10,000 shares exercised on March 25, 2025 pursuant to this option vested on May 31, 2022. |
| 7 | Derivative | Director Stock Option (Right to buy) | 2025-03-25 | M | D | 5,000 | $0.00 | 20,000 | D | $13.29 · — to 2029-05-31 | 5,000 Class A Common Stock | (F4) The 5,000 shares exercised on March 25, 2025 pursuant to this option vested on May 31, 2022. Of the remaining 20,000 shares subject to this option, 7,500 shares vested on May 31, 2022, and 12,500 vested on May 31, 2023. |